Intra-Cellular Therapies, Inc. - COM (ITCI)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
96.3M
Holdings value Q2 2024
$6.6B
Value change Q2 2024
+$647M
Grand Portfolio weight change Q2 2024
+0.001%
Number of holders
367
Number of buys Q2 2024
214
Number of sells Q2 2024
-163
Average buys Q2 2024 %
+0.004%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 45.8K $3.35M -$2.94M $73.17 5
2024 Q2 96.3M $6.6B +$647M $68.49 368
2024 Q1 87M $6.02B -$142M $69.20 338
2023 Q4 89.3M $6.4B +$284M $71.62 328
2023 Q3 86.1M $4.49B +$72.9M $52.09 288
2023 Q2 84.1M $5.33B +$44.4M $63.32 284
2023 Q1 83.6M $4.53B +$29M $54.15 270
2022 Q4 83M $4.39B -$2.67M $52.92 278
2022 Q3 83.1M $3.87B +$65.7M $46.53 256
2022 Q2 81.2M $4.64B +$44.4M $57.08 253
2022 Q1 80.5M $4.92B +$734M $61.19 232
2021 Q4 68.1M $3.56B +$18.8M $52.34 201
2021 Q3 68.3M $2.55B +$46.6M $37.28 173
2021 Q2 66.9M $2.73B -$34.3M $40.82 181
2021 Q1 68M $2.3B +$32.4M $33.93 162
2020 Q4 67.1M $2.13B +$101M $31.80 174
2020 Q3 63.8M $1.63B +$385M $25.66 173
2020 Q2 48.8M $1.25B +$59.1M $25.67 150
2020 Q1 47.2M $725M +$133M $15.37 137
2019 Q4 38M $1.3B -$41.7M $34.31 138
2019 Q3 39.8M $298M -$2.56M $7.47 129
2019 Q2 38.4M $497M +$34.7M $12.98 133
2019 Q1 38.3M $467M +$6.91M $12.18 131
2018 Q4 37.9M $432M -$15.5M $11.39 130
2018 Q3 38.1M $827M -$21.3M $21.70 134
2018 Q2 39.2M $692M -$3.73M $17.67 128
2018 Q1 39.4M $829M +$31.4M $21.05 130
2017 Q4 38.2M $553M -$43M $14.48 130
2017 Q3 40.8M $640M +$153M $15.78 137
2017 Q2 30.9M $384M +$13.3M $12.42 98
2017 Q1 29.3M $476M +$46.8M $16.25 114
2016 Q4 29.7M $448M +$33.3M $15.09 125
2016 Q3 27.9M $425M -$110M $15.24 127
2016 Q2 30.1M $1.17B +$49M $38.82 138
2016 Q1 29.1M $809M +$7.28M $27.80 125
2015 Q4 28.5M $1.53B +$39.1M $53.79 131
2015 Q3 27.9M $1.12B +$395M $40.04 130
2015 Q2 18.1M $577M +$34.6M $31.95 92
2015 Q1 17M $405M +$112M $23.88 74
2014 Q4 12.2M $215M +$2.35M $17.65 46
2014 Q3 12.1M $166M -$574K $13.71 47
2014 Q2 12.1M $204M +$17.7M $16.86 55
2014 Q1 11M $201M +$201M $18.18 35